Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 1;21(1):138.
doi: 10.1186/s12902-021-00800-y.

Interactions between Caveolin-1 (rs3807992) polymorphism and major dietary patterns on cardio-metabolic risk factors among obese and overweight women

Affiliations

Interactions between Caveolin-1 (rs3807992) polymorphism and major dietary patterns on cardio-metabolic risk factors among obese and overweight women

Faezeh Abaj et al. BMC Endocr Disord. .

Abstract

Background: Caveolin-1 (CAV-1) is a cholesterol-dependent essential component located in caveolae. Several studies have been CAV-1 related to cardio-metabolic parameters in animal models, however, there are few studies in humans. Importantly, there is no study has investigated the interaction between CAV-1 rs3807992 gene and dietary patterns (DPs) on cardio-metabolic risk factors.

Methods: The current cross-sectional study was conducted on 404 overweight and obese women. Dietary intake was obtained from FFQ with 147 items. The CAV-1 genotype was measured by the PCR-RFLP method. The anthropometric measurements, serum lipid profile, and inflammatory markers were measured by standard protocols.

Results: There was a significant interaction between CAV-1 rs3807992 and healthy DP on high-density cholesterol (HDL) (P-interaction = 0.03), TC/HDL (P-interaction = 0.03) and high sensitivity C-reactive protein (hs-CRP) (P-interaction = 0.04); in A-allele carriers, higher following a healthy DP was related to a higher level of HDL and lower TC/HDL and hs-CRP. As well as, the significant interactions were observed between CAV-1 rs3807992 and unhealthy DP in relation to triglyceride (TG) (P-interaction = 0.001), aspartate aminotransferase (AST) (P-interaction = 0.01) and monocyte chemoattractant protein-1(MCP-1) (P-interaction = 0.01); A-allele carriers were more following the unhealthy DP had lower levels of TG, AST and MCP-1.

Conclusions: Our study revealed a significant gene-diet interaction between rs3807992 SNPs and DPs in relation to cardio-metabolic risk factors; A-allele carriers might be more sensitive to dietary composition compared to GG homozygotes. Following a healthy DP in A-allele-carriers may be improved their genetic association with cardio-metabolic risk factors.

Keywords: Cardio-metabolic; Caveolin-1; Diet; Gene-environment interaction; Personalized diet; Polymorphism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
The interaction between Cav-1 SNP rs807992 and healthy dietary pattern on; (a) HDL, (b) TC, (c) hs-Crp, (d) MCP-1, (e) TC/HDL (f) LDL/HDL
Fig. 2
Fig. 2
The interaction between Cav-1 SNP rs807992 and Unhealthy dietary pattern on; (a) TG, (b) AST, (c) MCP-1, (d) LDL/HDL, (e) PAI-1and (f) LDL

Similar articles

Cited by

References

    1. World Health Organization . Global status report on noncommunicable diseases. Geneva: WHO; 2014. - PubMed
    1. McMillan DC, Sattar N, McArdle CS. ABC of obesity. obesity and cancer. BMJ. 2006;333(7578):1109–1111. doi: 10.1136/bmj.39042.565035.BE1. - DOI - PMC - PubMed
    1. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. Jama. 1999;282(16):1523–1529. doi: 10.1001/jama.282.16.1523. - DOI - PubMed
    1. Cannon CP. Cardiovascular disease and modifiable cardiometabolic risk factors. Clin Cornerstone. 2007;8(3):11–28. doi: 10.1016/S1098-3597(07)80025-1. - DOI - PubMed
    1. Bowen KJ, Sullivan VK, Kris-Etherton PM, Petersen KS. Nutrition and cardiovascular disease-an update. Curr Atheroscler Rep. 2018;20(2):8. doi: 10.1007/s11883-018-0704-3. - DOI - PubMed